Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Paraneoplastic neurologic autoimmune diseases].

R Voltz1

  • 1Institut für Klinische Neuroimmunologie, Klinikum Grosshadern, München, Germany. rvoltz@nro.med.uni-muenchen.de

Der Nervenarzt
|October 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Proposal for participation in intensive care and emergency medicine studies for patients unable to give informed consent (Cologne Model)].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2023
Same author

National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.

BMC palliative care·2022
Same author

EAN guideline on palliative care of people with severe, progressive multiple sclerosis.

European journal of neurology·2020
Same author

[Palliative medicine and psychiatry-a contraintuitive relationship?]

Der Nervenarzt·2020
Same author

[Depression, anxiety, delirium and desire to die in palliative care : Recommendations of the S3 guideline on palliative care for patients with incurable cancer].

Der Nervenarzt·2020
Same author

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.

European journal of neurology·2018
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Paraneoplastic neurologic syndromes are complications not directly caused by the tumor. Specific antibodies in patients with these syndromes help confirm diagnosis and detect associated cancers.

Area of Science:

  • Neurology
  • Oncology
  • Immunology

Context:

  • Paraneoplastic neurologic syndromes (PNS) were historically diagnosed by exclusion.
  • The discovery of specific antibodies has revolutionized PNS diagnosis.

Purpose:

  • To elucidate the diagnostic and prognostic significance of antibodies in paraneoplastic neurologic syndromes.
  • To highlight the role of antibody detection in identifying underlying malignancies.

Summary:

  • Paraneoplastic neurologic syndromes encompass tumor complications unrelated to direct tumor effects or common causes.
  • The identification of specific antibodies, such as anti-Hu, in approximately two-thirds of PNS patients confirms the diagnosis.
  • These antibodies demonstrate high specificity for certain tumor types, aiding in occult cancer detection.

Related Experiment Videos

Impact:

  • Antibody testing provides definitive etiological proof for PNS in nearly all cases.
  • Specific antibody profiles facilitate targeted tumor screening, improving patient outcomes.
  • This diagnostic approach enhances the understanding and management of complex neurological-oncological conditions.